The FDA announced on November 6, 2017, that West-Ward Pharmaceuticals Corp. voluntarily recalled Dexamethasone Sodium Phosphate Injection due to failed impurity specifications. The recall affects 16,157 shelf packs distributed nationwide.
How to tell if you have it
- Brand: West-Ward
- Product: Dexamethasone Sodium Phosphate Injection, USP, 4 mg/mL, 1 mL Vials (NDC 0641-6145-01)
- Packaging: 25 x 1 mL Vials per shelf pack (NDC 0641-6145-25)
- Lot codes: 106390, 106393, 106395
- Expiration date: 10/18
The hazard
The product failed to meet specifications for Dexamethasone adduct (related compound), resulting in high out-of-specification results. The recall is classified as Class III.
Context
GovInfoNow's records show West-Ward Pharmaceuticals Corp. has 4 other recalls on record since August 18, 2016. Other recent recalls of similar products include Somerset Therapeutics Dexamethasone Injection Recall (February 4, 2026), Sun Pharmaceutical Fluocinolone Acetonide Solution Recall (December 30, 2025), and Rising Pharma Recalls Temozolomide 5mg Capsules Due to Impurity Issues (March 3, 2026).